Overview

By bringing innovative products to market, pharmaceutical companies help people live longer, higher-quality lives — and our attorneys and other professionals are dedicated to facilitating that progress. Our professionals include former in-house counsel and senior executives for some of the world’s largest pharmaceutical companies, as well as an interdisciplinary team of experienced attorneys and professionals who provide regulatory, transactional, litigation, intellectual property and government affairs services tailored to the pharmaceutical industry. We help clients tackle business and financing pressures, regulatory scrutiny and litigation threats on a national and international scale. We have steered global pharma companies through multibillion-dollar transactions and helped international drug manufacturers accelerate drug development through creative joint ventures. Our IP attorneys work to patent your inventions in countries around the globe — and shield your brands through trademark policing and anti-counterfeiting strategies — freeing you to focus on product development and innovation. We serve as outside general counsel for regulatory compliance matters and support on all interactions with the Food and Drug Administration and other regulatory parties, including inspections, investigations and enforcement. And when disputes occur, our trial lawyers are there to handle any issue. Whether enforcing your rights or defending against alleged wrongdoing, including in product liability litigation, our team of skilled trial attorneys is ready to represent you in high-stakes, bet-the-company litigation every day.

Insights & Events

Latest
发表文章 March 2023

Something Tastes Different: Is Medication Flavoring Compounding?

1 min read  
发表文章 February 2023

As States Begin to Legalize ‘Magic’ Mushroom Use, Boards of Pharmacy and Pharmacists Should Stay Alert and Informed

2 min read  
Press Release February 2023

Faegre Drinker Elevates 6 Consulting Professionals to Principal

3 min read  
发表文章 January 2023

Meeting Report: The ALPHA Project — A Stakeholder Meeting on Lupus Clinical Trial Outcome Measures and the Patient Perspective

1 min read  
最新 January 2023

Delaware Chancery MFW Framework Does Not Require Best Deal

6 min read  
Speaking Engagement Recap December 06, 2022

Assessing the Impact of the Recent Supreme Court Session on the Drug and Medical Device Industry and Upcoming Preemption Battles

ACI’s 2022 Drug & Medical Device Litigation Conference
1 min read  
Speaking Engagement Recap December 06, 2022

Overcoming the Trials and Tribulations of Plaintiff Census Forms and Registries: What’s Working, What’s Not, and How Proposed MDL Rule Changes May Improve the System

ACI’s 2022 Drug & Medical Device Litigation Conference
2 min read  
发表文章 September 2022

FDA Proposes National Licensure Standards for Wholesale Drug Distributors and Third-Party Logistics Providers

1 min read  
发表文章 September 2022

Lawyers That ‘Look Like Me’: How and Why Women in Voir Dire Can Change Trial Dynamics

7 min read  
News June 2022

The Legal 500 Recognizes Faegre Drinker Practices and Attorneys in 2022 Edition

5 min read  
The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.